128 related articles for article (PubMed ID: 32297135)
21. Iodine-131-labeled meta-iodobenzylguanidine therapy of children with neuroblastoma: program planning and initial experience.
Shusterman S; Grant FD; Lorenzen W; Davis RT; Laffin S; Drubach LA; Fahey FH; Treves ST
Semin Nucl Med; 2011 Sep; 41(5):354-63. PubMed ID: 21803185
[TBL] [Abstract][Full Text] [Related]
22. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
[TBL] [Abstract][Full Text] [Related]
23. Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.
Kraal KC; van Dalen EC; Tytgat GA; Van Eck-Smit BL
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010349. PubMed ID: 28429876
[TBL] [Abstract][Full Text] [Related]
24. Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases.
van Santen HM; Tytgat GA; van de Wetering MD; van Eck-Smit BL; Hopman SM; van der Steeg AF; Nieveen van Dijkum EJ; van Trotsenburg AS
Thyroid; 2012 Jun; 22(6):643-6. PubMed ID: 22524499
[TBL] [Abstract][Full Text] [Related]
25. Whole-body dosimetry for individualized treatment planning of 131I-MIBG radionuclide therapy for neuroblastoma.
Buckley SE; Chittenden SJ; Saran FH; Meller ST; Flux GD
J Nucl Med; 2009 Sep; 50(9):1518-24. PubMed ID: 19713562
[TBL] [Abstract][Full Text] [Related]
26. Role of radio-iodinated meta-iodo benzyl guanidine in assessment of children with neuroblastoma at NEMROCK.
Abd El-Aal H
J Egypt Natl Canc Inst; 2006 Dec; 18(4):375-81. PubMed ID: 18301461
[TBL] [Abstract][Full Text] [Related]
27. [131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].
Stanková J; Kavan P; Krízová H; Hermanská E; Dosel P; Sázel M
Cas Lek Cesk; 2001 Jan; 140(1):13-7. PubMed ID: 11242978
[TBL] [Abstract][Full Text] [Related]
28. Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging.
Pandit-Taskar N; Zanzonico P; Hilden P; Ostrovnaya I; Carrasquillo JA; Modak S
Clin Nucl Med; 2017 Oct; 42(10):741-748. PubMed ID: 28759518
[TBL] [Abstract][Full Text] [Related]
29. Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma.
van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
Cancer; 2003 Jul; 98(2):389-96. PubMed ID: 12872361
[TBL] [Abstract][Full Text] [Related]
30. Targeted radiotherapy of multicell neuroblastoma spheroids with high specific activity [125I]meta-iodobenzylguanidine.
Roa WH; Miller GG; McEwan AJ; McQuarrie SA; Tse J; Wu J; Wiebe LI
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):425-32. PubMed ID: 9607361
[TBL] [Abstract][Full Text] [Related]
31. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
[TBL] [Abstract][Full Text] [Related]
32. High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.
van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
Cancer; 2002 Apr; 94(7):2081-9. PubMed ID: 11932913
[TBL] [Abstract][Full Text] [Related]
33. Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with (131)I-mIBG, a Targeted Radionuclide.
Edmondson DA; Karski EE; Kohlgruber A; Koneru H; Matthay KK; Allen S; Hartmann CL; Peterson LE; DuBois SG; Coleman MA
Radiat Res; 2016 Sep; 186(3):235-44. PubMed ID: 27556353
[TBL] [Abstract][Full Text] [Related]
34. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
[TBL] [Abstract][Full Text] [Related]
35. Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma.
Clement SC; van Rijn RR; van Eck-Smit BL; van Trotsenburg AS; Caron HN; Tytgat GA; van Santen HM
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):706-15. PubMed ID: 25512056
[TBL] [Abstract][Full Text] [Related]
36. Radiation exposure to comforters and carers during paediatric molecular radiotherapy.
Gains JE; Walker C; Sullivan TM; Waddington WA; Fersht NL; Sullivan KP; Armstrong E; D'Souza DP; Aldridge MD; Bomanji JB; Gaze MN
Pediatr Blood Cancer; 2015 Feb; 62(2):235-239. PubMed ID: 25284346
[TBL] [Abstract][Full Text] [Related]
37. [131-I-meta-iodo-benzyl-guanidine therapy in childhood neuroblastoma.].
Gilitsch A; Vojcek Á; Mezősi E; Bán Z; Csernus K; Ottóffy G
Orv Hetil; 2023 Oct; 164(39):1550-1555. PubMed ID: 37778009
[TBL] [Abstract][Full Text] [Related]
38. A model for in situ plan of care for a critically unstable pediatric patient following I-131 MIBG infusion.
Flori HR; Mwenesi R; Scott A; Conrad CM; Quinn JA; Ostwani W; Fischer KW; Yanik GA
Pediatr Blood Cancer; 2020 Nov; 67(11):e28665. PubMed ID: 32827342
[TBL] [Abstract][Full Text] [Related]
39. 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.
French S; DuBois SG; Horn B; Granger M; Hawkins R; Pass A; Plummer E; Matthay K
Pediatr Blood Cancer; 2013 May; 60(5):879-84. PubMed ID: 23024113
[TBL] [Abstract][Full Text] [Related]
40. Nurses' Experiences Caring for Children With Neuroblastoma Receiving
Lankin K; LaFond CM; Yost A
J Pediatr Hematol Oncol Nurs; 2023; 40(2):82-90. PubMed ID: 36691381
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]